Hepatitis C virus infection in USA: an estimate of true prevalence. - Wikidata - wikimedia - TriplyDB

Hepatitis C virus infection in USA: an estimate of true prevalence.

Hepatitis C virus infection in USA: an estimate of true prevalence.

http://www.wikidata.org/entity/Q37899936

about

Spotlight on grazoprevir-elbasvir once-daily combination and its potential in the treatment of hepatitis C Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review Hepatitis B and Hepatitis C Reactivation in the Biologic Era The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications Hepatitis C cirrhosis: New perspectives for diagnosis and treatment Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective Best strategies for global HCV eradication.Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe Hepatitis C screening Outlier populations: individual and social network correlates of solvent-using injection drug users Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009 Estimating the prevalence of hepatitis C infection in New York City using surveillance data Follow-up testing for hepatitis C virus infection: an analysis of Massachusetts surveillance data, 2007-2010.Hepatitis C viremia is associated with cytomegalovirus IgG antibody levels in HIV-infected women.Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA Frontiers in the treatment of hepatitis C virus infection.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study.Comparison of Hepatitis C Virus RNA and antibody detection in dried blood spots and plasma specimens.Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states Relationship of hepatitis C virus infection with diabetes in the U.S. population.Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.Economic burden of hepatitis C-associated diseases in the United States.Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians.Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection.Current and future disease progression of the chronic HCV population in the United States.Age cohort differences in illicit drug use and hepatitis C among African American substance users Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy.

P2860

Q26740233-8A32E527-5F5B-4A01-A075-181FD3E62E94 Q26781741-CF063B2C-B142-460E-B507-DA3328E415C2 Q26781993-F8632173-E97A-463E-963E-EA2E3AFBD63D Q26795559-DC6CE287-257A-481F-B84B-17462FDCDC62 Q26798477-D9BAB711-2C6F-4141-AB22-DD1484C818F2 Q26799924-8B3B02FF-4814-422A-8B69-604A8447866B Q26822903-A8FFCAAF-A488-4829-A277-FD19E91DC93C Q26825762-1C1105B1-04F1-401A-AA59-9D97D0FE17C2 Q26827517-D91CCD01-1B9D-43B2-B693-5414D486CA76 Q27693824-54D124A2-C37B-4D52-8211-FE0CE5246B08 Q28079580-B47E9DE4-BB5D-409C-A9BB-C74659C999E3 Q28083429-C02860C0-7327-4A5C-8D31-4DDD8F242DFB Q28539716-B0FB430D-4BD4-4672-B1C9-4C0EA59FE4B0 Q28540864-75857E44-684A-4DA3-8E5A-048EF3908DA6 Q28546457-3E07209C-3164-4BE3-B61C-9F55DA5368C6 Q30622845-8AB738BE-0FEC-441D-AF82-AE5D810C973C Q30846888-31618D51-E67E-4E02-99EF-8152E7EF1DE4 Q31115875-56B91FF8-B898-4946-ACF6-8E9F5D305733 Q31168171-E5D596FF-EDDE-4B68-9808-477568D3D157 Q33447050-BBAA7477-1AA3-47AB-8F5C-C3F35908E978 Q33571517-242125C5-0D5E-4E90-9190-900A3B3ACE13 Q33576161-F5DA1938-DF07-4506-BE63-A041E4A82ABE Q33621614-A36531F4-6849-4422-9BB6-4B18A7FEFFAB Q33629380-16E803C7-ED3F-457D-AB8F-469381662B7C Q33631170-9ABC7DDF-F903-460E-A3AE-CC3E1BC1894E Q33696050-9EE539D4-31B6-4307-A2E1-6E3693ABB80F Q33774344-311821A4-EA82-458F-87B7-361E67B38B8C Q33840930-856CB3A2-97BD-47C5-A540-84911BB7DE37 Q33853664-C43D58B5-F23E-4CA1-9B1E-30AD65508648 Q33925494-F898EA45-57E9-4E74-8EA1-8E9CF8904D78 Q34005936-38C529DD-105E-4B01-AD21-C8E24644E2AC Q34008754-3092CF58-7380-42D5-9077-1500C0877410 Q34077806-EC6ECAD3-740A-4394-8869-B40A10926109 Q34253963-6D13B828-3D75-4DEB-8C97-E3DEFC2C07A7 Q34310417-FC4C1AB8-BD2E-4A82-80A1-6C5FC23B7200 Q34718623-4998E670-6AE7-422A-B5EE-D3D35E0C9392 Q34736149-8E1B8497-1BA6-4831-B836-DE1FCB360C4A Q34737843-DCA900A3-8FC0-4DD7-861C-D4118EF44786 Q34765207-20D7C52B-E927-4A63-B935-823456485FA9 Q34873114-9F0788DF-2D0D-4CD1-9434-64B4E4515159

P2860

Hepatitis C virus infection in USA: an estimate of true prevalence.

http://www.wikidata.org/entity/Q37899936

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hepatitis C virus infection in USA: an estimate of true prevalence.

@en

Hepatitis C virus infection in USA: an estimate of true prevalence.

@nl

type

label

Hepatitis C virus infection in USA: an estimate of true prevalence.

@en

Hepatitis C virus infection in USA: an estimate of true prevalence.

@nl

prefLabel

Hepatitis C virus infection in USA: an estimate of true prevalence.

@en

Hepatitis C virus infection in USA: an estimate of true prevalence.

@nl

P1433

Q37899936-6FC2B669-0F4B-42C7-8408-DF3B76176038

P1476

Q37899936-26D0170D-9D2A-4C4A-82B4-253BCE09D950

P2093

Q37899936-0BC73C7B-2F14-45CD-9BAA-D1DDD0A011EE

Q37899936-4D1BE324-A3AF-4D70-ABA0-EE5364D74872

Q37899936-5BAB58C7-6D42-4AC3-9C19-3C6EDECEFDF1

Q37899936-F91717BC-05A3-473D-913A-AFC4B8494F33

Q37899936-FC713548-ABFF-46A0-B4ED-C75BC8AA298D

P2860

Q37899936-0D76A292-095C-496E-91B0-A3FADE9C3196

Q37899936-0E9AB654-7C50-401A-B24B-338F04091DE7

Q37899936-0F107795-58B6-40EE-9610-FB1970A22D67

Q37899936-0F7183C7-D367-4AAF-8A41-B70D53FFBE5B

Q37899936-19CAB756-C5E6-430B-B80E-8B102D2FF736

Q37899936-2D2AF627-1F3D-4936-93CC-EA92C69E0352

Q37899936-2E84ADBB-26D9-41A6-A3B8-D8D4800CA258

Q37899936-2E9652A7-2315-4E4E-8311-992B4FD83755

Q37899936-301F1426-2DEE-42BE-AD43-57537A83FAE8

Q37899936-3036E159-DAB9-4BF9-AA6D-6A08AEA73B17

P304

Q37899936-F8136E58-F41E-4F0E-B6E1-CECD45E7054A

P31

Q37899936-DB68DF9B-A96D-4DC4-BE22-7F1C1AEA78C8

P356

Q37899936-02D27E51-F13B-4D37-8FCC-DB068450E31A

P433

Q37899936-BA679168-C272-4EC8-8DDB-6C471850733E

P478

Q37899936-81A1A45A-12BE-4245-BC2C-B8CE5E56DB28

P577

Q37899936-35CF6A8D-79E0-4C59-8295-5C1CF77E6713

P5875

Q37899936-2DA3612E-970B-40E3-9D9D-8FFAD2DBBCA1

P698

Q37899936-6891C55D-C24A-45D2-BCFA-1356C2C3F185

P356

J.1478-3231.2011.02494.X

P1433

Liver International

P1476

Hepatitis C virus infection in USA: an estimate of true prevalence.

@en

P2093

Andrew H Talal

http://www.w3.org/2001/XMLSchema#string

Eric Chak

http://www.w3.org/2001/XMLSchema#string

Eugene R Schiff

http://www.w3.org/2001/XMLSchema#string

Kenneth E Sherman

http://www.w3.org/2001/XMLSchema#string

Sammy Saab

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and risk factors for bloodborne exposure and infection in correctional healthcare workers

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons

Prevention of needlesticks in emergency medical system workers

Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user

Hepatitis C virus infection in san francisco’s HIV-infected urban poor

Hepatitis C virus infection

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva.

Lessons learned from a peri-urban needle exchange.

P304

1090-1101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2011.02494.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51482769

http://www.w3.org/2001/XMLSchema#string

P698

21745274

http://www.w3.org/2001/XMLSchema#string